Screener
Amneal Pharmaceuticals, Inc. AMRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s operating margin?
- Amneal Pharmaceuticals, Inc. (AMRX) reported operating margin of 14.6% in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s operating margin changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s operating margin increased by 10.4% year-over-year, from 13.2% to 14.6%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s operating margin?
- Over 4 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s operating margin has grown at a 30.0% compound annual growth rate (CAGR), from 4.6% to 13.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Amneal Pharmaceuticals, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude